1
|
Jusu SM, Obayemi JD, Salifu AA, Nwazojie CC, Uzonwanne V, Odusanya OS, Soboyejo WO. Drug-encapsulated blend of PLGA-PEG microspheres: in vitro and in vivo study of the effects of localized/targeted drug delivery on the treatment of triple-negative breast cancer. Sci Rep 2020; 10:14188. [PMID: 32843673 PMCID: PMC7447811 DOI: 10.1038/s41598-020-71129-0] [Citation(s) in RCA: 36] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Accepted: 08/10/2020] [Indexed: 01/08/2023] Open
Abstract
Triple-negative breast cancer (TNBC) is more aggressive and difficult to treat using conventional bulk chemotherapy that is often associated with increased toxicity and side effects. In this study, we encapsulated targeted drugs [A bacteria-synthesized anticancer drug (prodigiosin) and paclitaxel] using single solvent evaporation technique with a blend of FDA-approved poly lactic-co-glycolic acid-polyethylene glycol (PLGA_PEG) polymer microspheres. These drugs were functionalized with Luteinizing Hormone-Releasing hormone (LHRH) ligands whose receptors are shown to overexpressed on surfaces of TNBC. The physicochemical, structural, morphological and thermal properties of the drug-loaded microspheres were then characterized using Fourier Transform Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), Dynamic Light Scattering (DLS), Nuclear Magnetic Resonance Spectroscopy (NMR), Thermogravimetric Analysis (TGA) and Differential Scanning Calorimetry (DSC). Results obtained from in vitro kinetics drug release at human body temperature (37 °C) and hyperthermic temperatures (41 and 44 °C) reveal a non-Fickian sustained drug release that is well-characterized by Korsmeyer-Peppas model with thermodynamically non-spontaneous release of drug. Clearly, the in vitro and in vivo drug release from conjugated drug-loaded microspheres (PLGA-PEG_PGS-LHRH, PLGA-PEG_PTX-LHRH) is shown to result in greater reductions of cell/tissue viability in the treatment of TNBC. The in vivo animal studies also showed that all the drug-loaded PLGA-PEG microspheres for the localized and targeted treatment of TNBC did not caused any noticeable toxicity and thus significantly extended the survival of the treated mice post tumor resection. The implications of this work are discussed for developing targeted drug systems to treat and prevent local recurred triple negative breast tumors after surgical resection.
Collapse
Affiliation(s)
- S M Jusu
- Department of Materials Science and Engineering, African University of Science and Technology, Km 10 Airport Road, Abuja, Nigeria
- Department of Mechanical Engineering, Worcester Polytechnic Institute, Worcester, MA, 01609, USA
| | - J D Obayemi
- Department of Mechanical Engineering, Worcester Polytechnic Institute, Worcester, MA, 01609, USA
- Department of Biomedical Engineering, Gateway Park Life Sciences Center, Worcester Polytechnic Institute (WPI), 60 Prescott Street, Worcester, MA, 01605, USA
| | - A A Salifu
- Department of Mechanical Engineering, Worcester Polytechnic Institute, Worcester, MA, 01609, USA
- Department of Biomedical Engineering, Gateway Park Life Sciences Center, Worcester Polytechnic Institute (WPI), 60 Prescott Street, Worcester, MA, 01605, USA
| | - C C Nwazojie
- Department of Materials Science and Engineering, African University of Science and Technology, Km 10 Airport Road, Abuja, Nigeria
| | - V Uzonwanne
- Department of Mechanical Engineering, Worcester Polytechnic Institute, Worcester, MA, 01609, USA
| | - O S Odusanya
- Biotechnology and Genetic Engineering Advanced Laboratory, Sheda Science and Technology Complex (SHESTCO), Abuja, Nigeria
| | - W O Soboyejo
- Department of Mechanical Engineering, Worcester Polytechnic Institute, Worcester, MA, 01609, USA.
- Department of Biomedical Engineering, Gateway Park Life Sciences Center, Worcester Polytechnic Institute (WPI), 60 Prescott Street, Worcester, MA, 01605, USA.
- Department of Materials Science and Engineering, Worcester Polytechnic Institute, Worcester, MA, 01609, USA.
| |
Collapse
|
2
|
Obayemi JD, Salifu AA, Eluu SC, Uzonwanne VO, Jusu SM, Nwazojie CC, Onyekanne CE, Ojelabi O, Payne L, Moore CM, King JA, Soboyejo WO. LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer. Sci Rep 2020; 10:8212. [PMID: 32427904 PMCID: PMC7237454 DOI: 10.1038/s41598-020-64979-1] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2019] [Accepted: 04/22/2020] [Indexed: 02/07/2023] Open
Abstract
Bulk chemotherapy and drug release strategies for cancer treatment have been associated with lack of specificity and high drug concentrations that often result in toxic side effects. This work presents the results of an experimental study of cancer drugs (prodigiosin or paclitaxel) conjugated to Luteinizing Hormone-Releasing Hormone (LHRH) for the specific targeting and treatment of triple negative breast cancer (TNBC). Injections of LHRH-conjugated drugs (LHRH-prodigiosin or LHRH-paclitaxel) into groups of 4-week-old athymic female nude mice (induced with subcutaneous triple negative xenograft breast tumors) were found to specifically target, eliminate or shrink tumors at early, mid and late stages without any apparent cytotoxicity, as revealed by in vivo toxicity and ex vivo histopathological tests. Our results show that overexpressed LHRH receptors serve as binding sites on the breast cancer cells/tumor and the LHRH-conjugated drugs inhibited the growth of breast cells/tumor in in vitro and in vivo experiments. The inhibitions are attributed to the respective adhesive interactions between LHRH molecular recognition units on the prodigiosin (PGS) and paclitaxel (PTX) drugs and overexpressed LHRH receptors on the breast cancer cells and tumors. The implications of the results are discussed for the development of ligand-conjugated drugs for the specific targeting and treatment of TNBC.
Collapse
Affiliation(s)
- J D Obayemi
- Department of Mechanical Engineering, Higgins Lab, 100 Institute Road, Worcester Polytechnic Institute (WPI), Worcester, MA, 01609, USA.,Department of Biomedical Engineering, Gateway Park Life Sciences Center, 60 Prescott Street, Worcester Polytechnic Institute (WPI), Worcester, MA, 01605, USA
| | - A A Salifu
- Department of Mechanical Engineering, Higgins Lab, 100 Institute Road, Worcester Polytechnic Institute (WPI), Worcester, MA, 01609, USA
| | - S C Eluu
- Department of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, 420110, Ifite Awka, Anambra State, Nigeria
| | - V O Uzonwanne
- Department of Mechanical Engineering, Higgins Lab, 100 Institute Road, Worcester Polytechnic Institute (WPI), Worcester, MA, 01609, USA
| | - S M Jusu
- Department of Material Science, African University of Science and Technology, Km 10 Airport Road, Abuja, Nigeria
| | - C C Nwazojie
- Department of Material Science, African University of Science and Technology, Km 10 Airport Road, Abuja, Nigeria
| | - C E Onyekanne
- Department of Material Science, African University of Science and Technology, Km 10 Airport Road, Abuja, Nigeria
| | - O Ojelabi
- RNA Therapeutics Institute, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA, 01605, USA
| | - L Payne
- Department of Psychiatry, Center for Comparative NeuroImaging, University of Massachusetts Medical School, 303 Belmont Street, Worcester, MA, 01604, USA
| | - C M Moore
- Department of Psychiatry, Center for Comparative NeuroImaging, University of Massachusetts Medical School, 303 Belmont Street, Worcester, MA, 01604, USA
| | - J A King
- Department of Psychiatry, Center for Comparative NeuroImaging, University of Massachusetts Medical School, 303 Belmont Street, Worcester, MA, 01604, USA.,Department of Biology & Biotechnology, Gateway Park Life Sciences Center, 60 Prescott Street (Gateway Park I), Worcester Polytechnic Institute (WPI), Worcester, MA, 01605, USA
| | - W O Soboyejo
- Department of Mechanical Engineering, Higgins Lab, 100 Institute Road, Worcester Polytechnic Institute (WPI), Worcester, MA, 01609, USA. .,Department of Biomedical Engineering, Gateway Park Life Sciences Center, 60 Prescott Street, Worcester Polytechnic Institute (WPI), Worcester, MA, 01605, USA.
| |
Collapse
|